Atezolizumab plus FOLFOX for Stage III Mismatch Repair–Deficient Colon Cancer

Original Article

F.A. Sinicrope, F.-S. Ou, D. Arnold, W.R. Peters, R.J. Behrens, C.H. Lieu, K. Matin, D.J. Cohen, S.L. Potter, A.B. Nixon, L.A. Kottschade, E. Kathol, W.L. Frankel, A. Shergill, D. Hsu, A. Reinacher-Schick, P. Mehan, P.J. Gold, M.F. Khalil, T. Zemla, C. Gatten, E.M. O’Reilly, and J.A. Meyerhardt

N Engl J Med 2026;394:1155-1166

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
03/25/2026
Course expires: 
03/26/2028

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please sign in or create an account to take the course.